Inhibition of the Prostaglandin EP-1 Receptor in Periosteum Progenitor Cells Enhances Osteoblast Differentiation and Fracture Repair


Fracture healing is a complex and integrated process that involves mesenchymal progenitor cell (MPC) recruitment, proliferation and differentiation that eventually results in bone regeneration. Prostaglandin E2 (PGE2) is an important regulator of bone metabolism and has an anabolic effect on fracture healing. Prior work from our laboratory showed EP1−/− mice have enhanced fracture healing, stronger cortical bones, higher trabecular bone volume and increased in vivo bone formation. We also showed that bone marrow MSCs from EP1−/− mice exhibit increased osteoblastic differentiation in vitro. In this study we investigate the changes in the periosteal derived MPCs (PDMPCs), which are crucial for fracture repair, upon EP1 deletion. EP1−/− PDMPCs exhibit increased numbers of total (CFU-F) and osteoblastic colonies (CFU-O) as well as enhanced osteoblastic and chondrogenic differentiation. Moreover, we tested the possible therapeutic application of a specific EP1 receptor antagonist to accelerate fracture repair. Our findings showed that EP1 antagonist administration to wild type mice in the early stages of repair similarly resulted in enhanced CFU-F, CFU-O, and osteoblast differentiation in PDMPCs and resulted in enhanced fracture callus formation at 10 days post fracture and increased bone volume and improved biomechanical healing of femur fractures at 21 days post fracture.

This is a preview of subscription content, log in to check access.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6


  1. 1.

    Abe, T., A. Kunz, M. Shimamura, P. Zhou, J. Anrather, and C. Iadecola. The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic. J. Cereb. Blood Flow Metab. 29(1):66–72, 2009.

    CAS  PubMed  Google Scholar 

  2. 2.

    Allen, M. R., J. M. Hock, and D. B. Burr. Periosteum: biology, regulation, and response to osteoporosis therapies. Bone 35(5):1003–1012, 2004.

    CAS  PubMed  Google Scholar 

  3. 3.

    Anderson, P., A. B. Carrillo-Galvez, A. Garcia-Perez, M. Cobo, and F. Martin. CD105 (endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities. PLoS ONE 8(10):e76979, 2013.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Asai, S., S. Otsuru, M. E. Candela, L. Cantley, K. Uchibe, T. J. Hofmann, K. Zhang, K. L. Wapner, L. J. Soslowsky, E. M. Horwitz, and M. Enomoto-Iwamoto. Tendon progenitor cells in injured tendons have strong chondrogenic potential: the CD105-negative subpopulation induces chondrogenic degeneration. Stem Cells 32(12):3266–3277, 2014.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Ashman, O., and A. M. Phillips. Treatment of non-unions with bone defects: which option and why? Injury 44(Suppl 1):S43–S45, 2013.

    PubMed  Google Scholar 

  6. 6.

    Bai, X. M., H. Jiang, J. X. Ding, T. Peng, J. Ma, Y. H. Wang, L. Zhang, H. Zhang, and J. Leng. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells. Life Sci. 86(5–6):214–223, 2010.

    CAS  PubMed  Google Scholar 

  7. 7.

    Balakumaran, A., P. J. Mishra, E. Pawelczyk, S. Yoshizawa, B. J. Sworder, N. Cherman, S. A. Kuznetsov, P. Bianco, N. Giri, S. A. Savage, G. Merlino, B. Dumitriu, C. E. Dunbar, N. S. Young, B. P. Alter, and P. G. Robey. Bone marrow skeletal stem/progenitor cell defects in dyskeratosis congenita and telomere biology disorders. Blood 125(5):793–802, 2015.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Bianco, P., X. Cao, P. S. Frenette, J. J. Mao, P. G. Robey, P. J. Simmons, and C. Y. Wang. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 19(1):35–42, 2013.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Bianco, P., S. A. Kuznetsov, M. Riminucci, and P. Gehron Robey. Postnatal skeletal stem cells. Methods Enzymol. 419:117–148, 2006.

    CAS  PubMed  Google Scholar 

  10. 10.

    Bianco, P., P. G. Robey, and P. J. Simmons. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2(4):313–319, 2008.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Brochhausen, C., P. Neuland, C. J. Kirkpatrick, R. M. Nusing, and G. Klaus. Cyclooxygenases and prostaglandin E2 receptors in growth plate chondrocytes in vitro and in situ—prostaglandin E2 dependent proliferation of growth plate chondrocytes. Arthritis Res Ther 8(3):R78, 2006.

    PubMed  PubMed Central  Google Scholar 

  12. 12.

    Chan, C. K., P. Lindau, W. Jiang, J. Y. Chen, L. F. Zhang, C. C. Chen, J. Seita, D. Sahoo, J. B. Kim, A. Lee, S. Park, D. Nag, Y. Gong, S. Kulkarni, C. A. Luppen, A. A. Theologis, D. C. Wan, A. DeBoer, E. Y. Seo, J. D. Vincent-Tompkins, K. Loh, G. G. Walmsley, D. L. Kraft, J. C. Wu, M. T. Longaker, and I. L. Weissman. Clonal precursor of bone, cartilage, and hematopoietic niche stromal cells. Proc Natl Acad Sci USA 110(31):12643–12648, 2013.

    CAS  PubMed  Google Scholar 

  13. 13.

    Chan, C. K., E. Y. Seo, J. Y. Chen, D. Lo, A. McArdle, R. Sinha, R. Tevlin, J. Seita, J. Vincent-Tompkins, T. Wearda, W. J. Lu, K. Senarath-Yapa, M. T. Chung, O. Marecic, M. Tran, K. S. Yan, R. Upton, G. G. Walmsley, A. S. Lee, D. Sahoo, C. J. Kuo, I. L. Weissman, and M. T. Longaker. Identification and specification of the mouse skeletal stem cell. Cell 160(1–2):285–298, 2015.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Chapple, C. R., P. Abrams, K. E. Andersson, P. Radziszewski, T. Masuda, M. Small, T. Kuwayama, and S. Deacon. Phase II study on the efficacy and safety of the EP1 receptor antagonist ONO-8539 for nonneurogenic overactive bladder syndrome. J. Urol. 191(1):253–260, 2014.

    CAS  PubMed  Google Scholar 

  15. 15.

    Coleman, R. A., W. L. Smith, and S. Narumiya. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 46(2):205–229, 1994.

    CAS  PubMed  Google Scholar 

  16. 16.

    Colnot, C. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J. Bone Miner. Res. 24(2):274–282, 2009.

    PubMed  Google Scholar 

  17. 17.

    Del Toro, Jr., F., V. L. Sylvia, S. R. Schubkegel, R. Campos, D. D. Dean, B. D. Boyan, and Z. Schwartz. Characterization of prostaglandin E(2) receptors and their role in 24,25-(OH)(2)D(3)-mediated effects on resting zone chondrocytes. J. Cell Physiol. 182(2):196–208, 2000.

    PubMed  Google Scholar 

  18. 18.

    Einhorn, T. A. The cell and molecular biology of fracture healing. Clin. Orthop. Relat. Res. 355(Suppl):S7–S21, 1998.

    Google Scholar 

  19. 19.

    Einhorn, T. A. The science of fracture healing. J. Orthop. Trauma 19(10 Suppl):S4–S6, 2005.

    PubMed  Google Scholar 

  20. 20.

    Fayaz, H. C., P. V. Giannoudis, M. S. Vrahas, R. M. Smith, C. Moran, H. C. Pape, C. Krettek, and J. B. Jupiter. The role of stem cells in fracture healing and nonunion. Int. Orthop. 35(11):1587–1597, 2011.

    PubMed  PubMed Central  Google Scholar 

  21. 21.

    Feigenson, M., R. A. Eliseev, J. H. Jonason, B. N. Mills, and R. J. O’Keefe. PGE2 receptor subtype 1 (EP1) regulates mesenchymal stromal cell osteogenic differentiation by modulating cellular energy metabolism. J. Cell. Biochem. 118(12):4383–4393, 2017.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Fujita, D., N. Yamashita, S. Iita, H. Amano, S. Yamada, and K. Sakamoto. Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells. Prostaglandins Leukot. Essent. Fatty Acids 68(5):351–358, 2003.

    CAS  PubMed  Google Scholar 

  23. 23.

    Fukumoto, K., N. Takagi, R. Yamamoto, Y. Moriyama, S. Takeo, and K. Tanonaka. Prostanoid EP1 receptor antagonist reduces blood–brain barrier leakage after cerebral ischemia. Eur. J. Pharmacol. 640(1–3):82–86, 2010.

    CAS  PubMed  Google Scholar 

  24. 24.

    Gerstenfeld, L. C., D. M. Cullinane, G. L. Barnes, D. T. Graves, and T. A. Einhorn. Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation. J. Cell. Biochem. 88(5):873–884, 2003.

    CAS  PubMed  Google Scholar 

  25. 25.

    Giannoudis, P. V., D. A. MacDonald, S. J. Matthews, R. M. Smith, A. J. Furlong, and P. De Boer. Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J. Bone Jt Surg. Br. 82(5):655–658, 2000.

    CAS  Google Scholar 

  26. 26.

    Granero-Molto, F., J. A. Weis, M. I. Miga, B. Landis, T. J. Myers, L. O’Rear, L. Longobardi, E. D. Jansen, D. P. Mortlock, and A. Spagnoli. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27(8):1887–1898, 2009.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Guan, Y., Y. Zhang, J. Wu, Z. Qi, G. Yang, D. Dou, Y. Gao, L. Chen, X. Zhang, L. S. Davis, M. Wei, X. Fan, M. Carmosino, C. Hao, J. D. Imig, R. M. Breyer, and M. D. Breyer. Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. J. Clin. Investig. 117(9):2496–2505, 2007.

    CAS  PubMed  Google Scholar 

  28. 28.

    Hall, A., S. H. Brown, C. Budd, N. M. Clayton, G. M. Giblin, P. Goldsmith, T. G. Hayhow, D. N. Hurst, A. Naylor, D. Anthony Rawlings, T. Scoccitti, A. W. Wilson, and W. J. Winchester. Discovery of GSK345931A: an EP(1) receptor antagonist with efficacy in preclinical models of inflammatory pain. Bioorg. Med. Chem. Lett. 19(2):497–501, 2009.

    CAS  PubMed  Google Scholar 

  29. 29.

    Hallinan, E. A., T. J. Hagen, R. K. Husa, S. Tsymbalov, S. N. Rao, J. P. vanHoeck, M. F. Rafferty, A. Stapelfeld, M. A. Savage, and M. Reichman. N-substituted dibenzoxazepines as analgesic PGE2 antagonists. J. Med. Chem. 36(22):3293–3299, 1993.

    CAS  PubMed  Google Scholar 

  30. 30.

    Holmes, C., T. S. Khan, C. Owen, N. Ciliberti, M. D. Grynpas, and W. L. Stanford. Longitudinal analysis of mesenchymal progenitors and bone quality in the stem cell antigen-1-null osteoporotic mouse. J. Bone Miner. Res. 22(9):1373–1386, 2007.

    PubMed  Google Scholar 

  31. 31.

    Hori, T., T. Oka, M. Hosoi, and S. Aou. Pain modulatory actions of cytokines and prostaglandin E2 in the brain. Ann. N. Y. Acad. Sci. 840:269–281, 1998.

    CAS  PubMed  Google Scholar 

  32. 32.

    Ishibashi, O., M. Ikegame, F. Takizawa, T. Yoshizawa, M. A. Moksed, F. Iizawa, H. Mera, A. Matsuda, and H. Kawashima. Endoglin is involved in BMP-2-induced osteogenic differentiation of periodontal ligament cells through a pathway independent of Smad-1/5/8 phosphorylation. J. Cell. Physiol. 222(2):465–473, 2010.

    CAS  PubMed  Google Scholar 

  33. 33.

    James, A. W. Review of signaling pathways governing MSC osteogenic and adipogenic differentiation. Scientifica (Cairo) 2013:684736, 2013.

    Google Scholar 

  34. 34.

    Jeffcoach, D. R., V. G. Sams, C. M. Lawson, B. L. Enderson, S. T. Smith, H. Kline, P. B. Barlow, D. R. Wylie, L. A. Krumenacker, J. C. McMillen, J. Pyda, and B. J. Daley. Nonsteroidal anti-inflammatory drugs’ impact on nonunion and infection rates in long-bone fractures. J Trauma Acute Care Surg. 76(3):779–783, 2014.

    CAS  PubMed  Google Scholar 

  35. 35.

    Kondo, T., H. Sei, T. Yamasaki, T. Tomita, Y. Ohda, T. Oshima, H. Fukui, J. Watari, and H. Miwa. A novel prostanoid EP1 receptor antagonist, ONO-8539, reduces acid-induced heartburn symptoms in healthy male volunteers: a randomized clinical trial. J Gastroenterol 2017.

    Article  PubMed  Google Scholar 

  36. 36.

    Kuznetsov, S. A., P. H. Krebsbach, K. Satomura, J. Kerr, M. Riminucci, D. Benayahu, and P. G. Robey. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J. Bone Miner. Res. 12(9):1335–1347, 1997.

    CAS  PubMed  Google Scholar 

  37. 37.

    Kuznetsov, S. A., M. H. Mankani, P. Bianco, and P. G. Robey. Enumeration of the colony-forming units-fibroblast from mouse and human bone marrow in normal and pathological conditions. Stem Cell Res. 2(1):83–94, 2009.

    PubMed  Google Scholar 

  38. 38.

    Levi, B., D. C. Wan, J. P. Glotzbach, J. Hyun, M. Januszyk, D. Montoro, M. Sorkin, A. W. James, E. R. Nelson, S. Li, N. Quarto, M. Lee, G. C. Gurtner, and M. T. Longaker. CD105 protein depletion enhances human adipose-derived stromal cell osteogenesis through reduction of transforming growth factor beta1 (TGF-beta1) signaling. J. Biol. Chem. 286(45):39497–39509, 2011.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Li, X., C. C. Pilbeam, L. Pan, R. M. Breyer, and L. G. Raisz. Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. Bone 30(4):567–573, 2002.

    CAS  PubMed  Google Scholar 

  40. 40.

    Mafi, R., S. Hindocha, P. Mafi, M. Griffin, and W. S. Khan. Sources of adult mesenchymal stem cells applicable for musculoskeletal applications—a systematic review of the literature. Open Orthop. J. 5(Suppl 2):242–248, 2011.

    PubMed  PubMed Central  Google Scholar 

  41. 41.

    Malmberg, A. B., M. F. Rafferty, and T. L. Yaksh. Antinociceptive effect of spinally delivered prostaglandin E receptor antagonists in the formalin test on the rat. Neurosci. Lett. 173(1–2):193–196, 1994.

    CAS  PubMed  Google Scholar 

  42. 42.

    Miki, T., M. Matsunami, S. Nakamura, H. Okada, H. Matsuya, and A. Kawabata. ONO-8130, a selective prostanoid EP1 receptor antagonist, relieves bladder pain in mice with cyclophosphamide-induced cystitis. Pain 152(6):1373–1381, 2011.

    CAS  PubMed  Google Scholar 

  43. 43.

    Minami, T., H. Nakano, T. Kobayashi, Y. Sugimoto, F. Ushikubi, A. Ichikawa, S. Narumiya, and S. Ito. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice. Br. J. Pharmacol. 133(3):438–444, 2001.

    CAS  PubMed  PubMed Central  Google Scholar 

  44. 44.

    Murao, H., K. Yamamoto, S. Matsuda, and H. Akiyama. Periosteal cells are a major source of soft callus in bone fracture. J. Bone Miner. Metab. 31(4):390–398, 2013.

    CAS  PubMed  Google Scholar 

  45. 45.

    Nakayama, Y., K. Omote, T. Kawamata, and A. Namiki. Role of prostaglandin receptor subtype EP1 in prostaglandin E2-induced nociceptive transmission in the rat spinal dorsal horn. Brain Res. 1010(1–2):62–68, 2004.

    CAS  PubMed  Google Scholar 

  46. 46.

    Negishi, M., Y. Sugimoto, and A. Ichikawa. Molecular mechanisms of diverse actions of prostanoid receptors. Biochim. Biophys. Acta 1259(1):109–119, 1995.

    PubMed  Google Scholar 

  47. 47.

    O’Connor, J. P., M. B. Manigrasso, B. D. Kim, and S. Subramanian. Fracture healing and lipid mediators. Bonekey Rep. 3:517, 2014.

    PubMed  PubMed Central  Google Scholar 

  48. 48.

    Ono, K., T. Akatsu, T. Murakami, M. Nishikawa, M. Yamamoto, N. Kugai, K. Motoyoshi, and N. Nagata. Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2. J. Endocrinol. 158(3):R1–R5, 1998.

    CAS  PubMed  Google Scholar 

  49. 49.

    Owen, M., and A. J. Friedenstein. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found. Symp. 136:42–60, 1988.

    CAS  PubMed  Google Scholar 

  50. 50.

    Pekcec, A., B. Unkruer, J. Schlichtiger, J. Soerensen, A. M. Hartz, B. Bauer, E. A. van Vliet, J. A. Gorter, and H. Potschka. Targeting prostaglandin E2 EP1 receptors prevents seizure-associated P-glycoprotein up-regulation. J. Pharmacol. Exp. Ther. 330(3):939–947, 2009.

    CAS  PubMed  Google Scholar 

  51. 51.

    Praemer, A., S. Furner, and D. P. Rice. Musculoskeletal Conditions in the United States. Rosemont, IL: American Academy of Orthopaedic Surgeons, 1999.

    Google Scholar 

  52. 52.

    Raisz, L. G. Physiologic and pathologic roles of prostaglandins and other eicosanoids in bone metabolism. J. Nutr. 125(7 Suppl):2024S–2027S, 1995.

    CAS  PubMed  Google Scholar 

  53. 53.

    Raisz, L. G. Prostaglandins and bone: physiology and pathophysiology. Osteoarthr. Cartil. 7(4):419–421, 1999.

    CAS  PubMed  Google Scholar 

  54. 54.

    Reynolds, D. G., S. Shaikh, M. O. Papuga, A. L. Lerner, R. J. O’Keefe, E. M. Schwarz, and H. A. Awad. muCT-based measurement of cortical bone graft-to-host union. J. Bone Miner. Res. 24(5):899–907, 2009.

    PubMed  Google Scholar 

  55. 55.

    Shamir, D., S. Keila, and M. Weinreb. A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro. Bone 34(1):157–162, 2004.

    CAS  PubMed  Google Scholar 

  56. 56.

    Simon, A. M., M. B. Manigrasso, and J. P. O’Connor. Cyclo-oxygenase 2 function is essential for bone fracture healing. J. Bone Miner. Res. 17(6):963–976, 2002.

    CAS  PubMed  Google Scholar 

  57. 57.

    Singh, A. K., and A. Sinha. Percutaneous autologous bone marrow injections for delayed or non-union of bones. J. Orthop. Surg. (Hong Kong) 21(2):267, 2013.

    Google Scholar 

  58. 58.

    Stock, J. L., K. Shinjo, J. Burkhardt, M. Roach, K. Taniguchi, T. Ishikawa, H. S. Kim, P. J. Flannery, T. M. Coffman, J. D. McNeish, and L. P. Audoly. The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure. J. Clin. Investig. 107(3):325–331, 2001.

    CAS  PubMed  Google Scholar 

  59. 59.

    Suda, M., K. Tanaka, K. Natsui, T. Usui, I. Tanaka, M. Fukushima, C. Shigeno, J. Konishi, S. Narumiya, A. Ichikawa, and N. Nakao. Prostaglandin E receptor subtypes in mouse osteoblastic cell line. Endocrinology 137(5):1698–1705, 1996.

    CAS  PubMed  Google Scholar 

  60. 60.

    Sugimoto, Y., and S. Narumiya. Prostaglandin E receptors. J. Biol. Chem. 282(16):11613–11617, 2007.

    CAS  PubMed  Google Scholar 

  61. 61.

    Suzawa, T., C. Miyaura, M. Inada, T. Maruyama, Y. Sugimoto, F. Ushikubi, A. Ichikawa, S. Narumiya, and T. Suda. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 141(4):1554–1559, 2000.

    CAS  PubMed  Google Scholar 

  62. 62.

    Tsutsumi, R., C. Xie, X. Wei, M. Zhang, X. Zhang, L. M. Flick, E. M. Schwarz, and R. J. O’Keefe. PGE2 signaling through the EP4 receptor on fibroblasts upregulates RANKL and stimulates osteolysis. J. Bone Miner. Res. 24(10):1753–1762, 2009.

    CAS  PubMed  PubMed Central  Google Scholar 

  63. 63.

    Ueno, M., K. Uchida, M. Takaso, H. Minehara, K. Suto, N. Takahira, R. Steck, M. A. Schuetz, and M. Itoman. Distribution of bone marrow-derived cells in the fracture callus during plate fixation in a green fluorescent protein-chimeric mouse model. Exp. Anim. 60(5):455–462, 2011.

    CAS  PubMed  Google Scholar 

  64. 64.

    Weinreb, M., D. Shamir, M. Machwate, G. A. Rodan, S. Harada, and S. Keila. Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity. Prostaglandins Leukot. Essent. Fatty Acids 75(2):81–90, 2006.

    CAS  PubMed  Google Scholar 

  65. 65.

    Xie, C., B. Liang, M. Xue, A. S. Lin, A. Loiselle, E. M. Schwarz, R. E. Guldberg, R. J. O’Keefe, and X. Zhang. Rescue of impaired fracture healing in COX-2−/− mice via activation of prostaglandin E2 receptor subtype 4. Am. J. Pathol. 175(2):772–785, 2009.

    CAS  PubMed  PubMed Central  Google Scholar 

  66. 66.

    Xu, H. H., L. Zhao, and M. D. Weir. Stem cell-calcium phosphate constructs for bone engineering. J. Dent. Res. 89(12):1482–1488, 2010.

    CAS  PubMed  PubMed Central  Google Scholar 

  67. 67.

    Zhang, M., M. Feigenson, T. J. Sheu, H. A. Awad, E. M. Schwarz, J. H. Jonason, A. E. Loiselle, and R. J. O’Keefe. Loss of the PGE2 receptor EP1 enhances bone acquisition, which protects against age and ovariectomy-induced impairments in bone strength. Bone 72:92–100, 2015.

    CAS  PubMed  Google Scholar 

  68. 68.

    Zhang, M., H. C. Ho, T. J. Sheu, M. D. Breyer, L. M. Flick, J. H. Jonason, H. A. Awad, E. M. Schwarz, and R. J. O’Keefe. EP1(−/−) mice have enhanced osteoblast differentiation and accelerated fracture repair. J. Bone Miner. Res. 26(4):792–802, 2011.

    CAS  PubMed  Google Scholar 

  69. 69.

    Zhang, X., A. Naik, C. Xie, D. Reynolds, J. Palmer, A. Lin, H. Awad, R. Guldberg, E. Schwarz, and R. O’Keefe. Periosteal stem cells are essential for bone revitalization and repair. J. Musculoskelet. Neuronal Interact. 5(4):360–362, 2005.

    CAS  PubMed  Google Scholar 

  70. 70.

    Zhang, X., C. Xie, A. S. Lin, H. Ito, H. Awad, J. R. Lieberman, P. T. Rubery, E. M. Schwarz, R. J. O’Keefe, and R. E. Guldberg. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J. Bone Miner. Res. 20(12):2124–2137, 2005.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references


Research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R01AR048681 (RJO).

Author information



Corresponding author

Correspondence to Regis J. O’Keefe.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Associate Editor Jane Grande-Allen oversaw the review of this article.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Feigenson, M., Jonason, J.H., Shen, J. et al. Inhibition of the Prostaglandin EP-1 Receptor in Periosteum Progenitor Cells Enhances Osteoblast Differentiation and Fracture Repair. Ann Biomed Eng 48, 927–939 (2020).

Download citation


  • EP1
  • Periosteum progenitor cells
  • Osteogenic differentiation and bone fracture